Hybrid nanostructures with combined functionalities can be rationally designed to achieve synergistic effects for efficient cancer treatment. Herein, a multifunctional nano-platform is constructed, containing an inner core of an anticancer drug MTX surrounding by a nanometer-thin layer of gold as the shell with Fe3O4 magnetic nanoparticles (NPs) evenly distributed in the gold layer, and the outermost hybrid LA-PEG-MTX molecules as surface coating agent (denoted as MFG-LPM NPs). This nanocomposite possesses very high drug loading capacity as the entire core is MTX and integrates magnetic-and active-targeting drug delivery, light-controlled drug release, magnetic resonance imaging (MRI), as well as photothermal and chemotherapy. With a strong near-infrared (NIR) absorbance at 808 nm, the nanocomposite enables temperature elevation and light-triggered MTX release. In vitro cytotoxicity studies indicate that the strategy of combining therapy leads to a synergistic effect with high cancer cell killing efficacy. In consistency with this, due to the high accumulation of MFG-LPM NPs at tumor site and their combinatorial chemophotothermal effects, 100% in vivo tumor elimination can be achieved. Additionally, in vivo MRI of tumor-bearing mice demonstrates an impressive performance of MFG-LPM NPs as a T2 contrast agent. Therefore, such multifunctional nanocomposite has the potential to serve as an excellent theranostic agent that collectively integrates multiple functions for efficient MRI guided cancer diagnosis and treatment.
The advancement of multifunctional hybrid nanostructures for cancer diagnosis and treatment has attracted continuously increasing attention in the field of nanotechnology and biomedicine. [1] [2] [3] [4] [5] [6] [7] For example, researchers have demonstrated that the combinatorial photothermal and chemotherapy can greatly improve the efficacy of cancer treatment and has the potential to overcome drug resistance. [8] [9] [10] Photothermal therapy (PTT) is an approach to employ photothermal agents with a strong absorbance in the near-infrared (NIR) region to produce heat to kill target cells with minimal side effects. During last decades, a wide range of PTT agents such as gold nanomaterials (e.g., gold nanorods, nanocages, and nanoshells), [11] [12] [13] [14] [15] carbon nanomaterials (e.g., carbon nanotubes, and graphene) [16] [17] [18] [19] [20] and many other materials (e.g., polydopamine, poly(4-styrenesulfonate), and indocyanine green (ICG)) [21] [22] have been widely explored. Chemotherapy is to use drugs to destroy cancer cells. For instance, methotrexate (MTX) has been commonly used in chemotherapy because the similarity of its molecule structure with folic acid lends itself an ability to combine with the overexpressed folate receptor on the surface of many types of cancer cells to effectively kill them. 23 For combinatorial therapy, Kim et al have previously demonstrated that, when MTX is combined with photothermal therapy for rheumatoid arthritis, the therapeutic efficacy of 0.05% dosage of MTX is comparable to that of the treatment with a full dose. 24 In using nanotechnology for these therapies, it is convenient to add different functions like surface modifying nanostructures with tumor recognizing ligands or guiding nanomaterials' movement under magnetic field to realize specific targeting to cancer. Beyond combination of these characteristics for therapy, if the nanostructures can be imaged, additional advantages will be realized as imaging is able to localize tumors, thereby precisely positioning laser irradiation for photothermal therapy, and enabling to monitor tumor development for determining subsequent therapy. [25] [26] This is very useful in further improving the efficacy of cancer treatment and meanwhile minimizing any potential negative effect. [27] [28] [29] Each of these designs has its merit and the combination is capable of generating synergistic effect. Therefore, it is highly desirable to construct a multifunctional theranostic agent in one single nanosystem to achieve the comprehensive advantages of nanotechnology for efficient cancer treatment and early diagnosis.
To fulfill this goal, it is important to carry out a rational design by identifying suitable imaging mode, therapeutics, and cancer targeting strategies. Among many imaging techniques, MRI has been widely used in clinic owing to its capacity of attaining 3D high-resolution images of living bodies and great imaging depth. 30 To further improve the imaging quality, iron oxide nanoparticles (IONP) are often utilized as a T2 contrast agent. 31 IONP has also been reported to achieve regulated drug release and targeted drug delivery under magnetic field. 32 For photothermal therapy, gold nanostructures have been extensively researched due to their strong absorption in the first biological window (e.g., 808 nm), high photothermal conversion efficiency, and great biocompatibility. 33 For chemotherapy, MTX can be directly self-assembled to the form of NPs without needing additional nanomaterials as a drug carrier, thereby achieving high drug load and potentially better safety profile. With these rationales, we developed a multifunctional nano-platform containing an inner core of MTX surrounding by a nanometer-thin layer of gold as the shell with Fe3O4 magnetic NPs evenly distributed in the gold layer, and the outermost hybrid LA-PEG-MTX molecules as surface coating (Scheme 1). Such architecture represents a nano-platform that can collectively achieve magnetic-and active-targeted drug delivery, light-controlled drug release, MRI, photothermal therapy and chemotherapy for efficient cancer treatment. In this work, we have prepared this nano-platform, systematically investigated their physical and chemical properties, pharmacokinetics, and in vivo biodistribution, as well as tested their application for MRI, in vitro cell killing, and in vivo anticancer therapy. Scheme 1. MFG-LPM NPs are accumulated in tumor site via magnetic field guided targeting and surface ligands driven targeting and then internalized by folic acidreceptor mediated endocytosis. Subsequently, NIR illumination is employed to generate heat for photothermal therapy and trigger the release of MTX for chemotherapy and iron oxide NPs for MRI. The synthesis of multifunctional NPs involved a multistep process. MTX NPs, the core of our designed nanocomposite, were prepared by a solvent exchange method. The digital image of a MTX NP suspension in water is shown in Figure S1 . These NPs are negatively charged and have an average diameter of about 180 nm, as indicated by their scanning electron microscopy (SEM) image presented in Figure S2 . The NPs were then surface functionalized with a cationic polymer poly(allylamine hydrochloride) (PAH) (M.W.: 15 kDa) by electrostatic interaction to obtain a positively charged surface ( Figure S3 ). This positive charge was made use to conjugate negatively charged Fe3O4
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NPs and gold nanoseeds on their surface through electrostatic attraction. Subsequently, hydroxylamine hydrochloride (NH2OH•HCl) was introduced to reduce the gold precursor chloroauric acid (HAuCl4) to form Au nanoshell on the surface of the nanocomposite. Figure S3 gives the values of the zeta-potential of different NPs at each stage of the preparation. Upon the modification of PAH to the initial negatively charged MTX NPs, the zeta potential switches from -3.42 to +34.76 mV. After the sequential conjugation of Fe3O4 NPs and gold nanoseeds on the surface of PAH-coated MTX NPs, the values of zeta potential of the nanostructures were respectively measured as +13. (Figure 1b and S4b) . At the end, to improve their water dispersity, biocompatibility, bioavailability, and specific targeting to folate receptor overexpressed cancer cells (Figure S5) , the as-prepared MFG NPs were functionalized by LA-PEG-MTX through gold-thiol bonds (referred to MFG-LPM NPs) ( Figure S6-8 ). 34, 35 The final NPs display a hydrodynamic diameter of approximately 188 nm and possess high stability (Figure S9 and S10). During the synthesis process, the surface plasmon resonance (SPR) peak of MTX NPs is broadened and significantly shifts to longer wavelengths after the formation of gold nanoshell on the surface (Figure 1c ).
This finding is consistent with previous reports involving similar Au nanoshells. 36 It suggests that a rather thin gold nanoshell have been successfully established on the surface of the nanocomposite. It is known that SPR can transform the energy of absorbed laser light to heat. 37 To investigate the influence of NIR laser irradiation on the temperature elevation, 3.0 mL of different concentrations of MFG-LPM NPs were placed in quartz cells and exposed to a 808 nm laser. Meanwhile, the temperature increase of water, PBS, RPMI 1640 medium and MTX NPs suspension was also studied for comparison. Evidently, the MFG-LPM NP suspensions lead to fast increase of temperature with extended irradiation time, while the control groups yield significantly smaller temperature changes. Moreover, a clear dose-dependent temperature increase profile is explored in the groups of MFG-LPM NPs from the figure. With the concentration of NPs increases from 5, 10, 20 to 40 μmol/L, the temperature increases by 16, 20, 25 and 30 °C, respectively (Figure 1d) . These data indicate that MFG-LPM NPs can readily rise the temperature of samples to above 47 °C and therefore have a great photothermal effect upon irradiation with NIR laser. 
Fast Release of MTX from MTX-LPM NPs Triggered by NIR Light
In Vitro Chemo-Photothermal Combination Therapy
To evaluate the efficacy of the dual-targeted photothermal cancer ablation of our designed NPs, different groups of KB cells were treated with MTX NPs, hollow Au nanoshells, MFG-LP NPs (multifunctional nanocomposite with LA-PEG surface coating), and MFG-LPM NPs (multifunctional nanocomposite with LA-PEG-MTX surface coating) with the same MTX concentration for 12 h, and then irradiated by a laser. For the group of hollow Au nanoshells, the Au amount remained the same as that in other groups. To enable magnetic field-aided targeted delivery of nanomedicine, a magnet was placed next to part of cells during experiments. A separate group of KB cells incubated with PBS solution was also studied for comparison. After laser irradiation, all groups of cells were further incubated for 12 h at 37 °C. Subsequently, the cells were stained with Calcine AM and propidium iodide (PI) to mark living (green) and dead (red) cells, respectively. For the two PBS groups with and without laser illumination, vast majority of cells is alive (Figure 2b) . This reveals that the used laser power is not sufficient to damage cells. In comparison, it is appealing to find that almost all cells incubated with MFG-LPM NPs are killed in the group with NIR light irradiation, while the cells in other groups are only partially killed after incubation, even To investigate the in vivo behaviors of MFG-LPM NPs, we firstly studied their pharmacokinetics. MFG-LPM NPs were administered to BALB/c mice through intravenous injection and the blood samples were collected after different time points.
In Vivo Blood Circulation and Biodistribution of MFG-LPM NPs
The concentrations of MFG-LPM NPs in blood were determined through measurement of Au 3+ by inductively coupled plasma atomic optical emission spectroscopy (ICP-OES). As shown in Figure 3a , the half-life of MFG-LPM NPs during blood circulation is approximately 2.9 h. As a comparison, the half-life of MTX free molecules is only 26.5 min. 39 The prolonged blood circulation of MFG-LPM NPs is probably a result of their surface PEG coating and also their particle size. The extended circulation time in blood will favor their accumulation in tumor site through the EPR effect. After studying the blood circulation of MFG-LPM NPs, we also interrogated their in vivo biodistribution profiles. In the experiments, 200 μL of MFG-LPM NPs with 0.5 mg/mL MTX were intravenously injected to 4T1 tumor-bearing BALB/c mice and the mice were sacrificed at 2, 6, 12 and 24 h afterwards. Next, three mice's major organs were collected followed by solubilization in aqua regia to determine the concentration of Au 3+ by ICP-OES. In one group, a magnet was placed next to the tumor to induce improved NP accumulation in the tumor site. The organs of an untreated mouse were used as controls to measure the Au background signal. The results indicate that high levels of MFG-LPM NPs are detected in tumors, liver and spleen in all groups (Figure   3b and S15). Attractively, the accumulation of MFG-LPM NPs in the tumor with applied magnetic field is constantly higher than others, demonstrating the advantage of combining surface ligands induced active targeting, magnetic field aid targeting, and the passive EPR effect. 40 Tumor imaging was performed in 4T1 tumor-bearing mice at one day after intravenous injection of MFG-LPM NPs. Firstly we demonstrated the MRI of tumors without magnetic field. As shown in Figure S16 , the tumors in both right and left sides show obvious darkening effects in T2-weighted MRI. Next, to achieve magnetic fieldaided targeting, a magnet was placed on the right side tumor of a mouse for 30 min. In this case, due to the magnetic field, majority of the MFG-LPM NPs will be transported to the right side tumor and very low amount is able to reach the left side (similar effect to the experiment shown in Figure 2b) . Therefore, the tumor in the left side displays very bright signal and the right side exhibits obvious darkening effects in T2-weighted MRI (Figure 3c) . These results suggest that MFG-LPM NPs can be simultaneously a contrast agent for MRI and a carrier for magnetic field-aided targeted drug delivery. When combining Au nanoshells for photothermal therapy and MTX for chemotherapy in Group Ⅶ (without magnetic field), the tumor growth is significantly inhibited with negligible increase in volume. When a boost injection is given, the tumor can be eliminated (the tumor inhibition rate is 100%). Most attractively, the tumors of the mice in Group Ⅷ can be effectively restrained and ablated only within a short period (the tumor inhibition rate is 100%), in which the mice were administered with MFG-LPM NPs and under the aid of magnetic field and NIR light. At one day after laser illumination, small scars were found on the skin of tumors with a dark gray color, eventually falling off on the 15 th day (Figure 4b) . There was no tumor recurrence during the 35-day experimental period. These findings clearly show that the integrated combination of magnetic-and active-targeted chemotherapy and photothermal treatments in MFG-LPM NPs provides an excellent synergistic effect. All of the mice in the group treated with MFG-LPM NPs and exposed to laser irradiation are able to survive in the whole observation period of 35 days, while the mice in all other groups have life spans from 21 to 34 days (Figure 4c ). The in vivo toxicity and possible side effects of nanomedicines have to be carefully studied before their potential application in clinic. To verify the applicability of MFG-LPM NPs in vivo, we measured the body weight of each mouse on daily basis during the treatment period. It is appealing that there is no dramatic weight loss in all groups (Figure 4d) . This indicates that our NPs do not possess acute toxicity at the administered dose. Then we carefully monitored the influences of MFG-LPM NPs on BALB/c mice in our experiment. The tumor bearing mice were sacrificed at the end of the treatment (35 days after the first dose) for blood analysis and histological examination (n = 5). The same analysis was also done to age-matched healthy mice for comparison (n = 5). The blood analysis (Figure 5a) indicates that no visible hepatic and kidney disorder is shown in the mice after treatment. Beyond this, the different biological indicators of the treated mice are within normal range (Figure 5b) . In organ histology, no sign of organ damage and inflammation was observed (Figure 5c ), suggesting the minimal side effects of MFG-LPM NPs in in vivo. The organ coefficients of liver, spleen, kidney, heart and lung in tumor bearing mice are 6.368±0.048%, 0.680±0.074%, 1.622±0.016%, 0.594±0.088% and 0.737±0.063%, respectively, very similar to those in healthy mice. Overall, all of these data evidence that MFG-LPM NPs induce no significant side effect in in vivo cancer therapy, demonstrating a significant prospect for efficient and safe cancer therapy in potential clinical applications.
In Vivo Targeted Chemo-Photothermal Therapy
In Vivo systematic toxicity
CONCLUSION
In summary, we have synthesized MFG-LPM NPs as a multifunctional platform to 
Characterization
The morphology of NPs were observed by SEM (FEI Quanta 200 FEG) and TEM (FEI Tecnai G2 F20 S-TWIN). The UV-vis absorption spectra of NPs were recorded using a Perkin-Elmer Lambda 750 UV/vis/NIR spectrophotometer. The amount of MTX was assessed from the absorbance of samples at 306 nm. Dynamic light scattering (DLS) analysis was carried out on a Zetasizer Nano ZS (Malvern Instruments, Malvern, U.K.) to determine the size and zeta potential of NPs. 1 H NMR spectra of samples in deuterated solvents were analyzed by a Bruker Avance 400 spectrometer.
Preparation of MTX NPs
MTX NPs were synthesized through solvent exchange. During the preparation, MTX/DMSO solution (250 µL, 1 × 10 -3 M) was dropwisely added to water (5 mL) under vigorous stirring. After 5 min stirring, the sample was incubated at room temperature for 72 hours.
Synthesis of Fe3O4 NPs
Fe3O4 NPs were prepared as follows: FeCl2•4H2O (1.148 g) and FeCl3 (1.057 g) were mixed in water (30 mL) under stirring followed by heating the mixture to 60 °C and keeping for 30 min. Subsequently, this mixture was added to NaOH solution (25 mL, 1 M) to obtain a black-colored mixture. Then more NaOH solution was dropwisely added until the pH value reached 11. Next, sodium citrate (0.248 g) was added and the mixture was heated to and kept at 80 °C for 1 h, followed by cooling to room temperature. The black product was then dissolved in ethanol. The undispersed residue was removed by centrifugation. At the end, these produced Fe3O4 NPs were redispersed in distilled water.
Preparation of Gold NPs
Gold NPs were synthesized by reducing chloroauric acid with sodium boronhydride (NaBH4). Briefly, sodium citrate solution (2 mL, 1.0 wt %) were added to 100 ml of deionized water and stirred for 3 min. Then HAuCl43H2O (1 mL, 1.0 wt %) was added with stirring. Five minutes later, NaBH4 (1 mL, 0.1 wt %) in sodium citrate solution (1.0 wt %) was promptly injected followed by 15 min reaction to obtain sodium citrate stabilized gold NPs.
Synthesis of LA-PEG-MTX, C18-PEG-MTX and C18-PEG-FA
We firstly produced Boc(NH)-PEG-LA according to previously reported method. 41 Subsequently, Boc(NH)-PEG-LA was reacted with trifluoroacetic acid (2 mL) for 24 h, followed by drying the reaction solution with nitrogen. The product was placed in 10 mL of water and undergone extraction by CH2Cl2. Next, the organic solvent was evaporated and the product was dissolved in water and then lyophilized (termed NH2-PEG-LA).
For production of MTX-PEG-LA, MTX (45.4 mg) were reacted with NHS (143.7 mg) in DMSO (5 mL) for 1 h the presence of EDC (38.3 mg), and then the mixture was added with NH2-PEG-LA (250 mg) for reaction of 24 h. At the end, the solution was placed in a dialysis bag (MWCO 5000) for 1-day dialysis followed by filtration and lyophilization. The product was indicated as MTX-PEG-LA.
The synthesis of C18-PEG-MTX and C18-PEG-FA were similar to that of PEG-MTX-LA except that LA and MTX were replaced with C18PMH and FA, respectively, in the reaction.
The chemical structures were confirmed by 1 H NMR. Figure S7 After Au nanoshell was formed on MTX NPs, the product was dispersed in DMSO to remove the core followed by centrifugation to obtain hollow Au nanoshells.
Release of MTX from MFG-LPM NPs
The release profiles of MTX from MFG-LPM NPs upon NIR laser irradiation were investigated at 37 °C. Two milliliters of MFG-LPM NPs suspension were placed in a dialysis bag (MWCO 5000) and then the bag was immersed into 50 mL of PBS with stirring. After 2 hours, the suspension was exposed to NIR laser irradiation for 10 min.
At different time internals, PBS (2 mL) containing liberated MTX were collected. The release pool was replenished with fresh PBS after each sample collection. The amount of the released MTX was measured by determining its absorbance at 306 nm. The experiments were performed in 3 replicates and the average was used in quantitative analysis.
Temperature elevation by MFG-LPM NPs
Three milliliters of different concentrations of MFG-LPM NPs were placed in quartz cuvettes and then exposed to NIR laser irradiation (808 nm, 1 W/cm 2 , 10 min; standard laser irradiation condition unless other stated). The temperature change of each sample was determined at every 30 s by a digital thermometer equipped with a thermocouple probe.
Cell Culture
Human nasopharyngeal epidermal carcinoma cell line (KB cell), normal human embryonic lung fibroblasts (MRC-5 cell) and murine breast cancer cell line (4T1 cell) were obtained from American Type Culture Collection (ATCC). KB cells, 4T1 cells and MRC-5 cells were cultured in RPMI-1640 medium supplemented with 10% FBS and 1% penicillin/streptomycin at 37 °C in a humidified atmosphere containing 5% of CO2. The cells were routinely passaged using trypsin (0.05%)/EDTA. For Calcine AM/PI test, KB cells which grown in FA (-) RPMI-1640 culture medium were cultured in a 35 mm dish for overnight.
Cytotoxicity Measurement
The in vitro cytotoxicity of different materials was determined by the MTT assay. KB, MRC-5 and 4T1 cells were individually seeded into 96-well plates (100 µL per well) followed by incubation for 24 h. Different groups of cells were then treated with different concentrations of MTX NPs, hollow Au nanoshells and MFG-LPM NPs for 24, 48 and 72 h. Some groups of the cells were exposed to NIR laser illumination while other groups were not irradiated by laser. Then the cells were incubated for different periods of time followed by treatment with MTT solution (20 µL, 5 mg/mL in PBS) and incubation for further 4 h. Finally, the medium was vacated and the cells were lysed by adding 150 µL of DMSO for MTT assay to measure the cell viabilities of different groups. The reported data represent the mean values of triplicate measurements.
Blood Circulation and Biodistribution
Ten microliters of blood were drawn from the tail vein of BALB/c mice at different time points after injection of MFG-LPM NPs. Then the blood samples were solubilized in one milliliter of lysis buffer containing 1% of SDS, 1% of Triton X-100, and 40 mM 
In Vivo MRI
A tumor-bearing mouse was intravenously injected with 200 μL of 0.5 mg/mL of MFG-LPM NPs. After injection, the right side tumor was placed under an external magnetic field for 30 min while the left one was not. T2-weighted MRI was recorded on a 3T clinical MRI scanner (Bruker Biospin Corporation, Billerica, MA, USA) equipped with small animal imaging coil.
In Vivo Chemo-Photothermal Therapy
The in vivo function of MFG-LPM NPs was studied in BALB/c mice bearing 4T1 tumor model. The experiments included 8 groups (n=6 in each group): PBS (Group Ⅰ ), PEGylated MTX NPs (Group Ⅱ), PEGylated MTX NPs with laser treatment (Group Ⅲ), hollow Au nanoshells with laser treatment (Group Ⅳ), PBS with laser treatment (Group Ⅴ), MFG-LPM NPs (Group Ⅵ), MFG-LPM NPs with laser treatment but without magnetic field (Group Ⅶ), MFG-LPM NPs with laser treatment and magnetic field (Group Ⅷ). The dose of MTX was maintained as 5 mg/Kg in the relevant groups.
The mice received two injections on day 0 and 7, except that the mice in Group Ⅷ had only one injection on day 0. At 24 h after each injection, an NIR laser was employed to irradiate tumors in Group Ⅲ, Ⅳ, Ⅴ, Ⅶ and Ⅷ. In the experimental period, the tumor dimensions and mouse weight were measured on daily basis. The tumor volume was calculated using the formula a × b 2 /2, where a is the largest and b the smallest diameter. The tumor volume and mouse body weight were normalized in comparison with their initial values. The organ coefficient was calculated with formula of organ weight / (body weight -tumor weight).
In Vivo Systematic Toxicity
After 35 days treatment, five mice from Group Ⅷ were sacrificed and blood samples and major organs and tissues including liver, spleen, kidney, heart, lung, intestine, stomach, skin, and muscle were collected. Five age-matched mice were used as a control group. Then the major organs and tissues were fixed in 10% neutral buffered formalin, processed routinely into paraffin, and sectioned to samples with 8 μm in thickness for hematoxylin and eosin (H&E) staining. The stained samples were examined under digital microscopy (Leica QWin). 
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